Solid Biosciences Inc. financial data

Symbol
SLDB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
500 Rutherford Avenue, 3 Rd Floor, Charlestown, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Solid Biosciences, LLC (to 1/25/2018)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.16K % +21.1%
Debt-to-equity 22.9 % -8.91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.6M shares +92.4%
Common Stock, Shares, Outstanding 38.6M shares +92.3%
Entity Public Float 51.5M USD +11.5%
Common Stock, Value, Issued 39K USD +95%
Weighted Average Number of Shares Outstanding, Basic 40.9M shares +108%
Weighted Average Number of Shares Outstanding, Diluted 40.9M shares +108%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 70.5M USD -11.6%
General and Administrative Expense 29.5M USD +0.91%
Operating Income (Loss) -100M USD +12.7%
Nonoperating Income (Expense) 9.34M USD -61.6%
Income Tax Expense (Benefit) 0 USD
Earnings Per Share, Basic -3.29 USD/shares +46.9%
Earnings Per Share, Diluted -3.29 USD/shares +46.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95.9M USD +4.68%
Cash, Cash Equivalents, and Short-term Investments 190M USD +18.8%
Assets, Current 198M USD +18%
Property, Plant and Equipment, Net 5.44M USD -26.4%
Operating Lease, Right-of-Use Asset 25.5M USD -8.38%
Other Assets, Noncurrent 515K USD +185%
Assets 231M USD +12.8%
Accounts Payable, Current 2.52M USD -15.1%
Accrued Liabilities, Current 9.92M USD -5.62%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 14.7M USD -7.43%
Operating Lease, Liability, Noncurrent 22.1M USD -6.56%
Other Liabilities, Noncurrent 96K USD
Liabilities 37.7M USD -7.95%
Accumulated Other Comprehensive Income (Loss), Net of Tax -15K USD -207%
Retained Earnings (Accumulated Deficit) -708M USD -14.7%
Stockholders' Equity Attributable to Parent 193M USD +18%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 126M USD -40.2%
Liabilities and Equity 231M USD +12.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.2M USD +10%
Net Cash Provided by (Used in) Financing Activities 107M USD
Net Cash Provided by (Used in) Investing Activities -38.5M USD -203%
Common Stock, Shares Authorized 120M shares +100%
Common Stock, Shares, Issued 38.6M shares +92.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 43.6M USD +370%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 97.8M USD +4.67%
Deferred Tax Assets, Valuation Allowance 91.7M USD -43.9%
Deferred Tax Assets, Gross 99M USD -42.3%
Operating Lease, Liability 24.6M USD -6.17%
Depreciation 2.58M USD +7.18%
Payments to Acquire Property, Plant, and Equipment 149K USD -70.6%
Lessee, Operating Lease, Liability, to be Paid 38.4M USD -10.2%
Property, Plant and Equipment, Gross 19.4M USD -0.11%
Operating Lease, Liability, Current 1.72M USD -6.96%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.11M USD -2.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.4M USD -3.89%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.8M USD -16.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.12M USD +0.76%
Deferred Tax Assets, Operating Loss Carryforwards 16.6M USD -76.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.24M USD +2.94%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 7.27M USD +1.3%
Interest Expense 88K USD -20.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%